ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Press Release
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology
Mar 14, 2023 22:05 JST
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full year ended December 31, 2022.
More info..
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
Mar 04, 2023 15:40 JST
Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the 'SAB') to provide strategic input based on their scientific knowledge and clinical expertise to help guide the further development of Prenetics' diagnostic cancer genomics platform.
More info..
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating
Jan 26, 2023 12:16 JST
It is reported that Cantor Fitzgerald initiated coverage on Prenetics Global (PRE.US) with "Overweight" rating and target price at USD7.00.
More info..
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
Jan 11, 2023 11:19 JST
Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced that ACT Genomics, a company which Prenetics recently acquired a majority stake in, has received clearance from the U.S. Food and Drug Administration (FDA) for ACTOnco
More info..
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics
Dec 16, 2022 19:57 JST
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, is acquiring a majority stake of ACT, an Asia based genomics company specializing in precision oncology with operations in Hong Kong, Taiwan, Japan, Singapore, Thailand and the UK, for an upfront consideration consisting of 19.9 million shares of Prenetics common stock and US $20 million cash (the "transaction").
More info..
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
Nov 30, 2022 22:43 JST
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and that it has been included as a constituent stock in the MSCI Global Micro Cap Index (Hong Kong), with such inclusion to become effective after the U.S. market close today.
More info..
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
Nov 10, 2022 21:36 JST
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the third quarter ended September 30, 2022.
More info..
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
Sep 09, 2022 21:54 JST
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the second quarter ended June 30, 2022.
More info..
1
Latest Release
PHOENIX HARMONIA, A Very Large LPG/Ammonia Carrier Constructed by Namura Shipbuilding, Enters into Service
Sep 29, 2023 17:11 JST
Stylish, Sporty, Spacious and All-Electric: Honda Prologue SUV Available Early Next Year with Anticipated EPA Range Rating of 300 Miles
Sep 29, 2023 14:31 JST
MHI Thermal Systems Scores Highly Again with Air-Conditioners for Australia and New Zealand Markets
Sep 29, 2023 11:51 JST
World's Best Honda Motorcycle Technician to be Determined at Inaugural Honda Global Motorcycle Technician Contest
Sep 29, 2023 11:05 JST
Eisai Launches New "Innovation" Page on Corporate Website
Sep 28, 2023 17:05 JST
Tokio Marine Nichido and Eisai Co-Develop Industry's First "Dementia Care Support Insurance"
Sep 28, 2023 14:49 JST
NEC sets record for 800 Gbps long-distance transmission over an optical submarine cable system
Sep 28, 2023 13:56 JST
JCB launches a special offer program in Hokkaido for inbound tourist to Japan
Sep 28, 2023 13:00 JST
OREX Announces OREX Open RAN Service Lineup
Sep 27, 2023 14:33 JST
Toyota and Woven by Toyota to Strengthen Ties Toward Accelerating Software Implementation
Sep 27, 2023 13:11 JST
Fujitsu delivers O-RAN ALLIANCE-compliant 5G virtualized RAN solution for NTT DOCOMO's 5G commercial network services
Sep 27, 2023 10:32 JST
DOCOMO to Transfer Ownership of 1,552 Telecommunication Towers to JTOWER to Promote Infrastructure Sharing
Sep 27, 2023 10:03 JST
MHI and ZutaCore Join Forces in a Strategic Alliance, Paving the Way for a Zero-emission Data Industry
Sep 27, 2023 09:00 JST
Overview of Honda Exhibits at the JAPAN MOBILITY SHOW 2023
Sep 26, 2023 17:25 JST
Fujitsu launches new technologies to protect conversational AI from hallucinations and adversarial attacks
Sep 26, 2023 11:02 JST
Fujitsu and iSurgery launch bone health promotion project in Japan with Jikei University School of Medicine aiming for early detection of osteoporosis
Sep 26, 2023 10:20 JST
Mitsubishi Motors to Showcase a Fulfilling Mobility Lifestyle that Awakens Drivers' Adventurous Spirit at the Japan Mobility Show 2023
Sep 25, 2023 17:50 JST
"LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan
Sep 25, 2023 15:17 JST
Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post-SDG Future'
Sep 25, 2023 03:00 JST
TOYOTA GAZOO Racing returns to South American roads
Sep 22, 2023 18:26 JST
More Latest Release >>